Permeability of a soft steroid, loteprednol etabonate, through an excised rabbit cornea

Journal of Ocular Pharmacology and Therapeutics

Volumn 12, Issue 2, 1996, Pages 159-167

  Reddy, Indra K ^a   Khan, Mansoor A ^a   Wu, Whei Mei ^b   Bodor, Nicholas S ^b  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; DIMETHYL SULFOXIDE; DRUG VEHICLE; HEPTAKIS(2,6 O DIMETHYL) BETA CYCLODEXTRIN; LOTEPREDNOL ETABONATE; POLYVINYL ALCOHOL; PROPYLENE GLYCOL; STEROID; TEARS PLUS; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CORNEA; CORNEA EPITHELIUM; DRUG DETERMINATION; DRUG PENETRATION; DRUG SCREENING; MALE; NONHUMAN; RABBIT;

EID: 0029885907     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1996.12.159     Document Type: Article

References (12)

1. Bodor, N. Designing safer drugs based on the soft drug approach. Trends Pharmac. Sci., 3:53-56,1982.
2. Bodor, N. Soft drugs: Principles and methods for the design of safe drugs. Med. Res. Rev., 3:449-469,1984.
3. Bodor, N. The application of soft drug approaches to the design of safer drugs. In. Topical Corticosteroid Therapy: A Novel Approach to Safer Drugs, Christopher, E. et al. eds. Raven Press, Ltd., New York, 1988, p. 13-25.
4. Bodor, N. Designing safer ophthalmic drugs. In Trends in Med. Chem. 88, Van der Goot, H., Domany, G. Pallos, L. and Timmerman, H. eds. Elsevier Science Publishers, B. V., Amsterdam, 1989, p. 145-164.
5. Bodor, N., El-Koussi, A., Kano, M. and Khalifa, M.N. Soft β-blockers for systemic and ophthalmic use. J. Med. Chem., 31:1651-1656,1988.
6. Bodor, N. and Varga, M. Effect of a novel soft steroid on the wound healing of rabbit cornea. Exp. Eve Res., 50:183-187,1990.
7. Druzgala, P. and Bodor, N. Selective 17α-alkylation of cortienic acid derivatives in a solid-liquid biphasic system. Synth. Com., 20:1133-1141,1990.
8. Bodor, N., Buris, S. and Buris, L. Novel soft steroids: Effects on cell growth in vitro and on wound healing in the mouse. Steroids. 56:434-439,1991.
9. Chien, D.S., Bundgaard, H. and Lee, V. H. L. Influence of corneal epithelial integrity on the penetration of timolol prodrugs. J. Ocular Pharmacol., 4:137-145,1988.
10. Alberth, M., Wu, W.M., Winwood, D. and Bodor, N. Lipophilicity, solubility and permeability of loteprednol etabonate: novel soft anti-inflammatory corticosteroids. J. Biopharm Sci., 2:115-125,1991.
11. Schoenwald, R.D. and Huang, H. Corneal penetration behavior of β-blocking agents I: Physicochemical factors. J. Pharm. Sci. 72:1266-1272,1983.
12. Kim, J.H., Green, K., Martinez, M. and Paton, D. Solute permeability of the corneal endothelium and descemet's membrane. Exp. Eye Res., 12:231-238,1971.